Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2026-04-13 @ 7:41 AM
Study NCT ID:
NCT00278460
Status:
COMPLETED
Last Update Posted:
2017-01-19
First Post:
2006-01-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor:
Wake Forest University Health Sciences
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lung Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | stage IV non-small cell lung cancer | View |
| None | stage IIIB non-small cell lung cancer | View |
| None | adenocarcinoma of the lung | View |
| None | bronchoalveolar cell lung cancer | View |
| None | large cell lung cancer | View |
| None | recurrent non-small cell lung cancer | View |
| None | squamous cell lung cancer | View |